Fidelity Select Biotechnology Pt Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 44 Posts
1 2 3
3 Best Performing Biotech Funds So Far In 2019
Article By: Zacks Investment Research Tuesday, December 3, 2019 1:00 PM EST
Investors who wish to make the best of the biotechnology industry’s gains could consider investing in mutual funds focused on biotechnology companies.
In this article: FBIOX, JFNAX, PRHSX Also: XBI, BIB
Read
4 Best Biotech Mutual Funds For Q4
Article By: Zacks Investment Research Saturday, October 26, 2019 4:38 PM EST
The beginning of this month marked an important period for investors eyeing the U.S. healthcare sector.
In this article: FBIOX, GGHYX, PRHSX, VGHCX
Read
4 Best-Performing Biotech Mutual Funds In 2019 So Far
Article By: Zacks Investment Research Friday, July 19, 2019 3:13 AM EST
After stumbling into the bear market territory in the second half of last year, the U.S. biotechnology sector recovered in the first six months of this year.
In this article: FBIOX, GGHYX, PRHSX, VGHCX Also: CRTX, TPTX, IBB, XBI, UBIO
Read
5 Best Low-Carbon Mutual Funds Focused On Clean Energy
Article By: Zacks Investment Research Wednesday, May 16, 2018 3:20 PM EST
We have selected five low-carbon mutual funds that have no or low exposure in fossil fuel stocks.
In this article: ANEFX, FBIOX, OLGAX, TRBCX, VINEX
Read
Biotech Poised For Growth: 3 Healthy Fund Choices
Article By: Zacks Investment Research Friday, November 24, 2017 12:53 PM EST
The Biotech industry is poised for growth. Biotech stocks have rallied throughout 2017, emerging as one of the top performers this year.
In this article: FBDIX, FBIOX, BIPIX Also: IBB, GILD, XBI
Read
5 Best-Performing Healthcare Mutual Funds In Q3
Article By: Zacks Investment Research Wednesday, November 8, 2017 12:32 PM EST
Broadly encouraging markets and continued investment initiatives have paved the way for the healthcare sector to become one of the top performers this year.
In this article: FBIOX, HIAHX, JAGLX, PRHSX, FSHCX Also: XLV
Read
5 Best-Performing Fidelity Mutual Funds Of Q3
Article By: Zacks Investment Research Friday, October 27, 2017 5:33 AM EST
Fidelity is expected to get more attention from investors in the coming months on the back of strong performance in the third quarter.
In this article: FBIOX, FKEMX, FOCKX, FSMEX, FSPTX Also: XLK
Read
Large Cap Biopharma Earnings Boost Stocks: Update Tuesday, Aug 1
Article By: Rod Raynovich Tuesday, August 1, 2017 10:42 PM EST
Stocks were broadly higher in July after financial reports. Now that earnings are in, track technicals and potential clinical catalysts for August/September which can be weak seasonally.
In this article: BMY, MBI, MRK, RHHBY, ALXN, IBB, REGN, AMGN, CELG, GILD, XBI, ABBV, BLUE, FMI, FBIOX, FBT
Read
Large Cap Biopharmaceutical Valuations: Q1 2017
Article By: Rod Raynovich Monday, May 8, 2017 8:45 PM EST
Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the valuation metrics.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read
Biotechs Running Again: Life Science Stocks
Article By: Rod Raynovich Tuesday, April 25, 2017 11:59 PM EST
Biotechs are running again taking the cue from Nasdaq which is up 3.44% in April after a brief mid-month sell-off. Biotech stocks rallied from global macro concerns which has dampened investor enthusiasm over the past two months.
In this article: BMY, FBIOX, IBB, QQQ, AMGN, GILD, XBI, XLV, ABBV, BLUE, FMI Also: RHHBY, BIIB
Read
5 Best Fidelity Mutual Funds To Buy In April
Article By: Zacks Investment Research Tuesday, April 4, 2017 2:56 PM EST
Fidelity Investments, the third-biggest fund family of the U.S. in terms of asset under management, is expected to get more love from investors in the coming months.
In this article: FBIOX, FCNTX, FDGRX, FOCPX, FSCSX Also: FLTMX, FIGFX, FMILX, FNMIX, FTBFX, XLK
Read
Vertex Soars On Clinical Data And Boosts Biotech Stocks
Article By: Rod Raynovich Wednesday, March 29, 2017 9:00 PM EST
Vertex Pharmaceuticals soared over 20% to $108 on released Phase 3 clinical data for their cystic fibrosis drug.
In this article: AET, CI, FBIOX, ALNY, ALXN, IBB, QQQ, REGN, VRTX, XBI, XLV, XPH, GWPH, ANTM, RDUS
Read
Biotech Rally Clipped By Trump Tweet; ACA Makeover Creates Uncertainty
Article By: Rod Raynovich Wednesday, March 8, 2017 2:00 AM EST
Just as investors were becoming more enthusiastic with biotechnology investing, a barrage of tweets and news stories regarding the ACA overhaul by Republicans cooled the market.
In this article: RHHBY, FBIOX, ALXN, ARRY, BMRN, IBB, REGN, ALKS, XBI, XLV, ICPT, ABBV, FMI, AUPH
Read
Biotech ETFs: Fidelity Biotech Fund Outperforms Ibb But Xbi Is Still The Leader
Article By: Rod Raynovich Friday, February 24, 2017 12:30 AM EST
Biotech stocks have outperformed the market YTD despite a bit of a sell-off recently. After two severe corrections in 2016 the Fidelity Select Biotechnology Fund has begun to emerge as a good play for less volatile larger caps in the sector.
In this article: FBIOX, IBB, FBT, XBI Also: ACAD, ARIA, INCY, REGN, SGEN, AMGN, CELG, CLVS, GILD, TSRO, QGEN, TECH, KITE
Read
Biotech Blahs: Out Of Favor But Great For Stock Pickers
Article By: Rod Raynovich Tuesday, January 3, 2017 2:49 AM EST
Biotech shares have faded since the November 14 top after the brief post-election rally. Although individual stocks have made good moves nothing has really changed.
In this article: ABBV, BLUE, BMY, FBIOX, HOLX, IBB, XBI, XLV, ABBV, BLUE, BMY, FBIOX, HOLX, IBB, XBI, XLV Also: ARIA, ARRY, GWPH, MDVN, TSRO
Read
Fidelity Select Funds: Best, Worst, And 2017 Forecast
Article By: Sam Subramanian Sunday, December 25, 2016 4:56 AM EST
2016 has reversed the fortunes of yesteryear's winners & losers. Energy stocks, which had clustered near the bottom of the annual performance table in 2014 and 2015 have risen to the top in 2016.
In this article: FBGRX, FBIOX, FCNTX, FPHAX, FSENX, FSESX, FSNGX, FSPHX Also: QQQ, DIA
Read
1 to 16 of 44 Posts
1 2 3